72 related articles for article (PubMed ID: 30028964)
1. Tumor-promoting and pro-angiogenic effects of roxarsone via VEGFR2/PLCγ/PKC signaling.
Pang Y; Wang K; Wang Y; Chenlin Z; Lei W; Zhang Y
Chem Biol Interact; 2018 Aug; 292():110-120. PubMed ID: 30028964
[TBL] [Abstract][Full Text] [Related]
2. Roxarsone induces angiogenesis via PI3K/Akt signaling.
Wang Y; Yin D; Xu C; Wang K; Zheng L; Zhang Y
Cell Biosci; 2016; 6():54. PubMed ID: 27708768
[TBL] [Abstract][Full Text] [Related]
3. VEGF/Flk1 Mechanism is Involved in Roxarsone Promotion of Rat Endothelial Cell Growth and B16F10 Xenograft Tumor Angiogenesis.
Chen S; Xu J; Wei Q; Zhao Z; Chen X; Cui H; Zhang Y
Sci Rep; 2019 Nov; 9(1):17417. PubMed ID: 31758020
[TBL] [Abstract][Full Text] [Related]
4. The VEGFR2/mTOR/S6K1 pathway involved in the angiogenic effects of roxarsone in vitro and in vivo.
Zhang M; Ding L; Zhou Z; Liu C; Wang C; Chen B; Chen X; Zhang Y
Toxicology; 2022 Aug; 478():153290. PubMed ID: 35985552
[TBL] [Abstract][Full Text] [Related]
5. Organoarsenic Roxarsone Promotes Angiogenesis In Vivo.
Zhang Y; Wang Y; Lu Q; Xin W; Cui W; Zhu J
Basic Clin Pharmacol Toxicol; 2016 Apr; 118(4):259-70. PubMed ID: 26450128
[TBL] [Abstract][Full Text] [Related]
6. In vitro and ex vivo angiogenic effects of roxarsone on rat endothelial cells.
Zhu J; Cui W; Liu X; Ying J; Hu C; Zhang Y
Toxicol Lett; 2013 Nov; 223(2):175-82. PubMed ID: 24035937
[TBL] [Abstract][Full Text] [Related]
7. Orally Administered Mucolytic Drug l-Carbocisteine Inhibits Angiogenesis and Tumor Growth in Mice.
Shinya T; Yokota T; Nakayama S; Oki S; Mutoh J; Takahashi S; Sato K
J Pharmacol Exp Ther; 2015 Sep; 354(3):269-78. PubMed ID: 26126534
[TBL] [Abstract][Full Text] [Related]
8. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
9. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
11. VEGFR1 and PKCα signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner.
Vartanian A; Stepanova E; Grigorieva I; Solomko E; Baryshnikov A; Lichinitser M
Melanoma Res; 2011 Apr; 21(2):91-8. PubMed ID: 21389833
[TBL] [Abstract][Full Text] [Related]
12. A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling.
Liu Y; He Y; Yang F; Cong X; Wang J; Peng S; Gao D; Wang W; Lan L; Ying X; Liu M; Chen Y; Yi Z
Sci China Life Sci; 2017 Feb; 60(2):202-214. PubMed ID: 28194552
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic potential of 3-nitro-4-hydroxy benzene arsonic acid (roxarsone).
Basu P; Ghosh RN; Grove LE; Klei L; Barchowsky A
Environ Health Perspect; 2008 Apr; 116(4):520-3. PubMed ID: 18414637
[TBL] [Abstract][Full Text] [Related]
14. NRP1 presented in trans to the endothelium arrests VEGFR2 endocytosis, preventing angiogenic signaling and tumor initiation.
Koch S; van Meeteren LA; Morin E; Testini C; Weström S; Björkelund H; Le Jan S; Adler J; Berger P; Claesson-Welsh L
Dev Cell; 2014 Mar; 28(6):633-46. PubMed ID: 24656741
[TBL] [Abstract][Full Text] [Related]
15. Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation.
Chen X; Yang G; Song JH; Xu H; Li D; Goldsmith J; Zeng H; Parsons-Wingerter PA; Reinecker HC; Kelly CP
PLoS One; 2013; 8(5):e64227. PubMed ID: 23675530
[TBL] [Abstract][Full Text] [Related]
16. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis.
Zhu GS; Tang LY; Lv DL; Jiang M
Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor upregulates expression of ADAMTS1 in endothelial cells through protein kinase C signaling.
Xu Z; Yu Y; Duh EJ
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4059-66. PubMed ID: 16936124
[TBL] [Abstract][Full Text] [Related]
18. GIT1 mediates VEGF-induced podosome formation in endothelial cells: critical role for PLCgamma.
Wang J; Taba Y; Pang J; Yin G; Yan C; Berk BC
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):202-8. PubMed ID: 19023093
[TBL] [Abstract][Full Text] [Related]
19. ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling.
Su M; Huang J; Li J; Qin X; Tang X; Jin F; Chen S; Jiang C; Zou Z; Peng K; Nuruzzaman M; Zhang J; Luo J; Liu S; Luo Z
Oncotarget; 2016 Apr; 7(14):19018-30. PubMed ID: 26967559
[TBL] [Abstract][Full Text] [Related]
20. Endothelial VEGFR2-PLCγ signaling regulates vascular permeability and antitumor immunity through eNOS/Src.
Sjöberg E; Melssen M; Richards M; Ding Y; Chanoca C; Chen D; Nwadozi E; Pal S; Love DT; Ninchoji T; Shibuya M; Simons M; Dimberg A; Claesson-Welsh L
J Clin Invest; 2023 Oct; 133(20):. PubMed ID: 37651195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
